Search details
1.
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
Invest New Drugs
; 33(1): 159-68, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25294187
2.
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel.
Oncologist
; 19(6): 616-22, 2014 Jun.
Article
in English
| MEDLINE | ID: mdl-24797823
3.
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Magn Reson Med
; 71(4): 1592-602, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23661583
4.
Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
J Card Fail
; 19(1): 10-5, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23273589
5.
Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.
Magn Reson Med
; 68(1): 261-71, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22127821
6.
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
Clin Breast Cancer
; 22(2): 103-114, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34903452
7.
Motion correction in diffusion-weighted MRI of the breast at 3T.
J Magn Reson Imaging
; 33(5): 1063-70, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21509862
8.
Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms.
Med Phys
; 37(6): 2541-52, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20632566
9.
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Cancer Chemother Pharmacol
; 85(4): 673-683, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32062691
10.
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Invest Radiol
; 50(4): 195-204, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25360603
11.
Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?
Ecancermedicalscience
; 8: 446, 2014.
Article
in English
| MEDLINE | ID: mdl-25114718
12.
A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
Phys Med Biol
; 56(17): 5753-69, 2011 Sep 07.
Article
in English
| MEDLINE | ID: mdl-21841212
13.
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.
Clin Cancer Res
; 16(2): 681-90, 2010 Jan 15.
Article
in English
| MEDLINE | ID: mdl-20068102
14.
Temporal sampling requirements for reference region modeling of DCE-MRI data in human breast cancer.
J Magn Reson Imaging
; 30(1): 121-34, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19557727
Results
1 -
14
de 14
1
Next >
>>